Vitamin D Status and Its Relation to Inflammatory Markers in Patients with Mild to Moderate Ulcerative Colitis
INTRODUCTION Vitamin D has a known role in calcium and phosphate homeostasis. In addition, vitamin D has been linked to autoimmune diseases such as multiple sclerosis, diabetes mellitus, and inflammatory bowel disease (IBD). Vitamin D deficiency (VDD) is defined as serum 25(OH)D levels less than 20 ng/mL (equals to 50 nmol/L). 4, 5 Levels of 21 to 29 ng/mL indicate insufficiency, and levels of 30 to 50 ng/mL are considered as sufficient vitamin D states.
6 Vitamin D intoxication occurs at serum 25(OH)D levels greater than 150 ng/mL.
5
IBD are autoimmune inflammatory status of the alimentary tract, mainly large and small intestine. Two main types of IBD include ulcerative colitis (UC) and Crohn's disease (CD). CD potentially affects the entire alimentary tract even the mouth, esophagus, and stomach, but UC affects colon and rectum. 7, 8 Interaction of environmental and genetic factors seems to cause IBD.
9 It may also be related to diet and nutritional states. A recent meta-analysis revealed that patients with IBD had higher odds of VDD than healthy controls. 10 Most organs including the immune cells, and small and large intestine express vitamin D receptors (VDRs).
11 Mucosal VDR is lower in patients with UC compared with controls. 12 In addition, the intestine of VDR knock-out murine is affected by spontaneous inflammation, 13 which supports the hypothesis that VDD might be related to IBD.
Since there is no up-to-date study on the prevalence of VDD in Iranian patients with UC, the aim of this study was to assess the vitamin D status and its correlation with erythrocyte sedimentation rate (ESR), and highsensitivity C-reactive protein (hs-CRP), as inflammatory markers, in patients with mild to moderate UC who were residents of Tehran.
MATERIALS AND METHODS
In 9 /L), and anti-Tumor necrosis factor-alpha (TNF-α) therapy, those who were taking any form of vitamin D3 supplement in the 3 months preceding the study, or those who had history of hyperparathyroidism, nephrolithiasis, malignancy, or renal or hepatic failure as well as those with pregnancy and breast feeding were not included. Of the patients, 39 declined to participate (response rate = 69/8%). Finally 90 patients with UC were assessed in December 2014. Blood sample were taken in plain tubes and the sera were separated by centrifuging at 2500 rpm for 10 min after 30 min at 37°C, and stored at -80°C. Circulating levels of 25(OH)D3 were determined using commercial ELISA kit (Calbiotech, CA, USA; Intra-assay variation < 6% and CV < 8%) according to manufacturer's instruction.
Serum hs-CRP levels were also measured using ELI-SA kit (Monobind, CA, USA) and PTH (parathyroid hormone) serum levels were assessed using ELISA kit (Euroimmun, Luebeck, Germany). ESRs were measured using ESR tube according to standard protocol. The demographic data were collected by personal interview using a short questionnaire specifically developed for this study.
The study was approved by the Ethics Committee of Tehran University of Medical Sciences (Ethic code: 9021324004-1), and written informed consent was obtained from all the participants.
Statistical analyses were performed using STATA V.
12
(Stata Statistical Software, College Station, TX, USA). The results are expressed as mean ± standard deviation (SD) or number (%). Pearson correlation was applied to examine the relation between variables.
RESULTS
In this cross-sectional study, 90 patients with mild to moderate UC (51 men and 39 women) were assessed. The mean age of the participants was 36. There was no significant differences between men and women neither in serum 25(OH)D (32.4 ± 8.2 and 34.1 ± 8.5 ng/mL, respectively, p = 0.32) nor in dietary vitamin D intake (182.7 ± 66.7 and 198.5 ± 66.1 ng/mL, respectively, p = 0.25).
DISCUSSION
The results of this cross-sectional study revealed that 38.9% of the patients with UC were vitamin D deficient or insufficient, and there was no significant correlation between serum 25(OH)D and hs-CRP, ESR, BMI, and disease duration.
Vitamin D is traditionally known for its substantial role in bone homeostasis, but recently it has been growing recognition of its immunological effects. [15] [16] [17] On the other hand, recent literature suggests that vitamin D levels are correlated with a wide spectrum of diseases especially autoimmune diseases such as IBD. 17 The hypothesis of relation between IBD and VDD has arisen from the studies that showed those people living in southern areas have a lower risk of IBD than those living in northern parts with low sunlight exposure, 18-21 which is along with geographical variation in vitamin D status caused by different exposure to ultraviolet B radiation.
In a study done in 2008, Heshmat and colleagues reported that only 13% of healthy Tehran inhabitants had sufficient serum vitamin D levels. 22 However, compared with our study, there were differences regarding cut-off, time of the assessment, and measuring methods. But it can be cautiously concluded that VDD in patients with UC in Tehran is not higher than healthy people. In another study only 21% of the patients with CD and 24% of the patients with UC had sufficient vitamin D levels, and vitamin D concentrations in the patients with UC were not affected by disease activity, and no correlation was seen with the inflammatory markers (CRP, fibrinogen, and ESR), 23 as was not seen in our study. Some other studies have reported similar 25(OH)D levels between healthy controls and patients with IBD, 24, 25 however, others have reported lower vitamin D concentrations in IBD. [26] [27] [28] In the study of Souza and co-workers 27 , 48.5% of the 37 patients with UC were vitamin D deficient.
VDD in patients with IBD could be a result of malnutrition, inadequate dietary intake of vitamin D, lower bioavailability, or reduced outdoor physical activity, which reduces sunlight exposure. 17, 29 It has been shown that vitamin D deficiency is common even in patients with newly diagnosed IBD, which suggests that low vitamin D may increase the incidence risk of IBD. 30 In our study the correlations between serum 25(OH)D and hs-CRP, ESR, BMI, and disease duration were weak and non-significant, but an RCT recently showed that vitamin D at higher doses may have a beneficial effect on inflammation in patients with UC, 31 which endorses that immunological effects of vitamin D may be achieved at serum levels higher than current accepted levels for bone homeostasis. 32, 33 There are some limitations in our study. First of all, we had no control group to obtain odds ratio for VDD in the patients. Secondly, of the 129 eligible patients, 39 (30%) declined to participate. Thirdly, in this study only patients with mild to moderate UC with ages between 18 and 50 years and BMI between 18.5 and 30 kg/m 2 have been assessed. 
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